Liesbeth Ferdinande
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Surgery top 10%
- Immunology top 10%
- Co-authors
- Claude CuvelierWim CeelenP DemetterDavid CreytensJo Van DorpeSylvie RotteyLouis LibbrechtTijl Vermassen
- Topics
- Sarcoma Diagnosis and Treatment (19 papers)Cancer Immunotherapy and Biomarkers (15 papers)Soft tissue tumor case studies (7 papers)
- Partner nations
- BelgiumNetherlandsGermany
In The Last Decade
Liesbeth Ferdinande
71 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 106
- Oncology 899
- Molecular Biology 484
- Pulmonary and Respiratory Medicine 481
- Surgery 346
- Immunology 296
Countries citing papers authored by Liesbeth Ferdinande
This map shows the geographic impact of Liesbeth Ferdinande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liesbeth Ferdinande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liesbeth Ferdinande more than expected).
Fields of papers citing papers by Liesbeth Ferdinande
This network shows the impact of papers produced by Liesbeth Ferdinande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liesbeth Ferdinande. The network helps show where Liesbeth Ferdinande may publish in the future.
Co-authorship network of co-authors of Liesbeth Ferdinande
This figure shows the co-authorship network connecting the top 25 collaborators of Liesbeth Ferdinande. A scholar is included among the top collaborators of Liesbeth Ferdinande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liesbeth Ferdinande. Liesbeth Ferdinande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 33 | |
| 8 | 4 | |
| 9 | 10 | |
| 10 | 10 | |
| 11 | 29 | |
| 12 | 45 | |
| 13 | 0 | |
| 14 | 1 | |
| 15 | Prolonged survival in a nasopharyngeal carcinoma (NPC) patient with metastatic disease : a case report | 0 |
| 16 | 0 | |
| 17 | 25 | |
| 18 | 99 | |
| 19 | Different expression patterns of indoleamine 2,3-dioxygenase in squamous cell carcinoma of tonsil and tongue | 2 |
| 20 | 52 |
About Liesbeth Ferdinande
Liesbeth Ferdinande is a scholar working on Biological Psychiatry, Oncology and Rheumatology, having authored 77 papers that have together received 2.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (19 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Soft tissue tumor case studies (7 papers). The work is most often cited by research in Biological Psychiatry (123 citations), Oncology (899 citations) and Otorhinolaryngology (90 citations). Liesbeth Ferdinande has collaborated with scholars based in Belgium, Netherlands and Germany. Frequent co-authors include Claude Cuvelier, Wim Ceelen, P Demetter, David Creytens, Jo Van Dorpe, Sylvie Rottey, Louis Libbrecht, Tijl Vermassen, Joost van Gorp and Astrid De Meulenaere. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.